Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;134(3):617-21.
doi: 10.1016/j.thromres.2014.06.032. Epub 2014 Jul 5.

Rivaroxaban for the Treatment of Venous Thromboembolism. A "Real-Life" Perspective in 103 Patients


Rivaroxaban for the Treatment of Venous Thromboembolism. A "Real-Life" Perspective in 103 Patients

Luis Jara-Palomares et al. Thromb Res. .

Erratum in

  • Thromb Res. 2015 Jul;136(1):182


Introduction: Randomized clinical trials have demonstrated non-inferiority of rivaroxaban compared with vitamin K antagonists (VKAs) in the treatment of venous thromboembolism (VTE). Our objective was to analyze in real life, tolerance, recurrence, bleeding and adverse events of rivaroxaban in patients with acute symptomatic VTE.

Material and methods: Open follow-up study of a cohort of patients aged 18 and over diagnosed with deep vein thrombosis (DVT) and/or pulmonary embolism (PE) treated with rivaroxaban from December 2011 to January 2014.

Results: The total number of patients treated with rivaroxaban was 103. The mean age was 58+/-17 years. The most frequent co-morbidities were: hypertension (30.0%), dyslipidemia (23.3%) and respiratory disease (25.2%). The type of thromboembolic event treated was: DVT (64.1%), PE (18.4%), DVT+PE (17.5%). Of the rivaroxaban-treated patients, 30% did so from the initial anticoagulant therapy and the other 70% in long-term or extended anticoagulant therapy. The median time of treatment with rivaroxaban was 6 months [corrected]. There was one recurrence and no deaths occurred. Six patients had bleeding, one of which was severe.

Conclusions: Rivaroxaban provides a therapeutic alternative in a group of patients with VTE with advantages over VKAs, because of the convenience in dosing, lack of requirements for periodic monitoring and limited interaction with other drugs.

Keywords: Anticoagulants; Pulmonary embolism; Rivaroxaban; Venous thromboembolism; Venous thrombosis.

Similar articles

See all similar articles

Cited by 4 articles

MeSH terms

LinkOut - more resources